A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
2021 · Signal Transduction and Targeted Therapy · 632 citations
https://doi.org/10.1038/s41392-020-00451-w
C
Cai He
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.4K
Citations
18
h-index
22
i10-index
Cai He is an academic researcher from Sichuan University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies & COVID-19 Clinical Research Studies. The author has an h-index of 18, co-authored 47 publications.
ORCID: 0000-0002-9959-1562Papers by this author
worksRecombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
2025 · Signal Transduction and Targeted Therapy · 15 citations
https://doi.org/10.1038/s41392-025-02139-5
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants
2024 · Signal Transduction and Targeted Therapy · 11 citations
https://doi.org/10.1038/s41392-024-02025-6
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
2025 · Signal Transduction and Targeted Therapy · 7 citations
https://doi.org/10.1038/s41392-025-02154-6
Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
2023 · Molecular Biomedicine · 5 citations
https://doi.org/10.1186/s43556-023-00121-7
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
2025 · Molecular Biomedicine · 5 citations
https://doi.org/10.1186/s43556-025-00258-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat